Cytek Biosciences
PublicCytek Biosciences is now publicly traded
The data on this page reflects Cytek Biosciences's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Went Public
Jul 22, 2021
Last Round
Series D
Nov 5, 2020
Total Funding Raised
$332M
Company Overview
Cytek is a biotechnology company specializing in advanced cell analysis solutions that utilize innovative technologies to provide high-resolution and high-sensitivity flow cytometry.
Sector
Healthcare
AI Layer
Non-AI
Keywords
Cytek Biosciences Comparables
Compare Cytek Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Beijing Challen Biotechnology Co., Ltd. | 77% | |
| LumaCyte | 66% | |
| Deepcell | 65% |
Cytek Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| IPO | Jul 22, 2021 | ||||
| Series D | Nov 5, 2020 | ||||
| Series C | Sep 25, 2018 | ||||
| Series B | Jan 25, 2017 |
Cytek Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| RA Capital Management | Series D |
| Co-win Ventures | Series A, Series B |
| Hillhouse Investment | Series D |
| Bencao Capital | Series C |
| F-Prime Capital | Series B, Series A |
| Eight Roads Ventures | Series B, Series A |
| Northern Light Venture Capital | Series C |
Cytek Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access